Efficacy and Safety of Linagliptin in Combination With Insulin in Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The objective of the current study is to investigate the efficacy, safety and tolerability of
linagliptin (5 mg / once daily) compared to Placebo during long term treatment (52 weeks and
longer) in combination with basal insulin in patients with type 2 diabetes mellitus with
insufficient glycaemic control.